The innovative drug Polyhemostat in the treatment of bleeding


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The innovative drug Polyhemostat has been designed and patented by Russian scientists and registered by the Ministry of Health of the Russian Federation. The drug has been undergone pre- and post-registration clinical studies in a number of leading Russian clinics and military hospitals. The paper considers the experience in topically applying Polyhemostat.

全文:

受限制的访问

作者简介

V. Zubritsky

Institute of Sociomedical Technologies, Moscow State University of Food Production

Professor

V. Kukes

Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation

Professor; MD, Academician of the Russian Academy of Sciences

R. Chilova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: rtchilova@gmail.com

V. Vechorko

O.M. Filatov City Clinical Hospital Fifteen

I. Tarasov

Lyubertsy District Hospital Two

Candidate of Medical Sciences

G. Proklova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

参考

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2018
##common.cookie##